Follow
Selena Lin
Selena Lin
JBS Science In
Verified email at jbs-science.com
Title
Cited by
Cited by
Year
Chromosome 1q21. 3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
JY Goh, M Feng, W Wang, G Oguz, SMJM Yatim, PL Lee, Y Bao, TH Lim, ...
Nature medicine 23 (11), 1319-1330, 2017
1422017
Detection of hypermethylated vimentin in urine of patients with colorectal cancer
BP Song, S Jain, SY Lin, Q Chen, TM Block, W Song, DE Brenner, YH Su
The Journal of Molecular Diagnostics 14 (2), 112-119, 2012
732012
Emerging utility of urinary cell-free nucleic acid biomarkers for prostate, bladder, and renal cancers
SY Lin, JA Linehan, TG Wilson, DSB Hoon
European urology focus 3 (2-3), 265-272, 2017
682017
Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues
S Jain, TT Chang, S Chen, B Boldbaatar, A Clemens, SY Lin, R Yan, ...
Scientific Reports 5 (1), 10478, 2015
582015
A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine
SY Lin, V Dhillon, S Jain, TT Chang, CT Hu, YJ Lin, SH Chen, KC Chang, ...
The Journal of Molecular Diagnostics 13 (5), 474-484, 2011
542011
Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma
S Jain, S Chen, KC Chang, YJ Lin, CT Hu, B Boldbaatar, JP Hamilton, ...
PloS one 7 (4), e35789, 2012
502012
Urine-based liquid biopsy for nonurological cancers
S Jain, SY Lin, W Song, YH Su
Genetic Testing and Molecular Biomarkers 23 (4), 277-283, 2019
482019
Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma
S Jain, TT Chang, JP Hamilton, SY Lin, YJ Lin, AA Evans, FM Selaru, ...
PLoS One 6 (11), e26799, 2011
392011
Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis
S Jain, L Xie, B Boldbaatar, SY Lin, JP Hamilton, SJ Meltzer, SH Chen, ...
Hepatology Research 45 (11), 1110-1123, 2015
362015
DNA markers in molecular diagnostics for hepatocellular carcinoma
YH Su, SY Lin, W Song, S Jain
Expert review of molecular diagnostics 14 (7), 803-817, 2014
302014
Rapid and sensitive detection of hepatitis B virus 1762T/1764A double mutation from hepatocellular carcinomas using LNA-mediated PCR clamping and hybridization probes
XD Ren, SY Lin, X Wang, T Zhou, TM Block, YH Su
Journal of virological methods 158 (1-2), 24-29, 2009
232009
Prospective molecular profiling of circulating tumor cells from patients with melanoma receiving combinatorial immunotherapy
SY Lin, SC Chang, S Lam, R Irene Ramos, K Tran, S Ohe, MP Salomon, ...
Clinical chemistry 66 (1), 169-177, 2020
222020
Urine DNA biomarkers for hepatocellular carcinoma screening
AK Kim, JP Hamilton, SY Lin, TT Chang, HW Hann, CT Hu, Y Lou, YJ Lin, ...
British journal of cancer 126 (10), 1432-1438, 2022
192022
Integrated assessment of circulating cell-free MicroRNA signatures in plasma of patients with melanoma brain metastasis
MA Bustos, KD Tran, N Rahimzadeh, R Gross, SY Lin, Y Shoji, ...
Cancers 12 (6), 1692, 2020
192020
Multiplex gene profiling of cell-free DNA in patients with metastatic melanoma for monitoring disease
SY Lin, SK Huang, KT Huynh, MP Salomon, SC Chang, DM Marzese, ...
JCO Precision Oncology 2, 1-30, 2018
192018
Characterization of the hepatitis B virus DNA detected in urine of chronic hepatitis B patients
S Jain, YH Su, YP Su, S McCloud, R Xue, TJ Lee, SC Lin, SY Lin, W Song, ...
BMC gastroenterology 18, 1-9, 2018
182018
Recurrent HBV integration targets as potential drivers in hepatocellular carcinoma
SY Lin, A Zhang, J Lian, J Wang, TT Chang, YJ Lin, W Song, YH Su
Cells 10 (6), 1294, 2021
152021
Detection of hepatitis B virus–host junction sequences in urine of infected patients
SY Lin, YP Su, ER Trauger, BP Song, EGC Thompson, MC Hoffman, ...
Hepatology Communications 5 (10), 1649-1659, 2021
122021
A new method for improving extraction efficiency and purity of urine and plasma cell-free DNA
SY Lin, Y Luo, MM Marshall, BJ Johnson, SR Park, Z Wang, YH Su
Diagnostics 11 (4), 650, 2021
112021
Detection of minimal residual disease and its clinical applications in melanoma and breast cancer patients
SY Lin, JIJ Orozco, DSB Hoon
Biological mechanisms of minimal residual disease and systemic cancer, 83-95, 2018
112018
The system can't perform the operation now. Try again later.
Articles 1–20